InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the detailed record of transactions filed by Friedl-Naderer Johanna, Directeur Commercial. Insider active across 2 companies, notably Dyne Therapeutics, Inc.. Aggregated, 3 reports have been published. Total volume traded: €7k. The latest transaction was filed on 13 May 2026 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
US$3,573228 shares@ US$15.67080.0001% mcap100.0% of flow
Common Stock
SEC:0001193125-26-223984·
€3,573228 shares@ €15.67080.0001% mcap50.0% of flow
Common Stock
SEC:0001193125-26-223984:0·
090,000 shares0
Common Stock
SEC:0001209191-22-016929:0·
3 of 3 declarations
About Friedl-Naderer Johanna
Johanna Friedl-Naderer is the Chief Commercial Officer and Chief Business Officer, Global at Dyne Therapeutics, Inc. and Vir Biotechnology, Inc. She is responsible for commercial strategy and international business direction for these biopharmaceutical companies. Her expertise in the commercial field contributes to the expansion and innovation of health products.
